Atanu Bhattacharjee - Epidemiology

Author Information

Atanu Bhattacharjee is affiliated with the Section of Biostatistics at the Center for Cancer Epidemiology, Tata Memorial Centre, Mumbai, India. His research focuses on various epidemiological aspects of cancer, including survival analysis, chemotherapy, and the impact of COVID-19 on cancer treatment.

Research Contributions

Atanu Bhattacharjee has made significant contributions to the field of cancer epidemiology and biostatistics. His recent work includes studies on SARS-CoV-2 reinfection, gene signatures for ovarian cancer survival, and the quality of life in patients with head and neck squamous cell carcinoma. He has also conducted research on missing data handling techniques, feature selection for high-dimensional survival data, and the determination of optimum biological doses for metronomic chemotherapy.

Aliases

A Bhattacharjee, A. Bhattacharjee, Atanu Bhattacharjee

Publication and Citation Metrics

Citation Count	1505
h-index	16
Paper Count	222

Publications:

SARS-CoV-2 reinfection after previous infection and vaccine breakthrough infection through the second wave of pandemic in India: An observational study

DOI: 10.1016/j.ijid.2022.02.037

Year: 2022

Identification of key gene signatures for the overall survival of ovarian cancer

DOI: 10.1186/s13048-022-00942-0

Year: 2022

RMAC study: A randomized study for evaluation of metronomic adjuvant chemotherapy in recurrent head and neck cancers post salvage surgical resection in those who are ineligible for re-irradiation.

DOI: 10.1016/j.oraloncology.2022.105816

Year: 2022

Quality of life in patients with locally advanced head and neck squamous cell carcinoma undergoing concurrent chemoradiation with once-a-week versus once-every-3-weeks cisplatin.

DOI: 10.1002/cam4.4715

Year: 2022

Missing data handling technique in joint modeling context

DOI: 10.1016/J.BEA.2021.100012

Year: 2021

Missing data handling technique to determine optimum biological dose

DOI: 10.1016/j.bea.2021.100012

Year: 2021

Feature Selection for High Dimensional Survival Data [R package highMLR version 0.1.0]

DOI:

Year: 2021

Determining an Optimum Biological Dose of A Metronomic Chemotherapy

DOI: 10.6339/JDS.201701_15(1).0005

Year: 2021

Locoregional recurrence after cystectomy in muscle invasive bladder cancer: Implications for adjuvant radiotherapy.

DOI: 10.1016/j.urolonc.2021.01.015

Year: 2021

Thresholding of prominent biomarkers of breast cancer on overall survival using classification and regression tree

DOI: 10.3233/cbm-210470

Year: 2021

What are the Treatment Options for Plasmodium Ovale?

How is a Propagated Source Attack Identified?

Who Should Wear Masks?

How Does Gene Ontology Facilitate Data Integration?

What is Peripheral Tolerance?

What Are the Challenges in Clinical Diagnosis?

How Do Research Outcomes Vary by Study Design?

What is the Role of Physicians in Epidemiology?

What is a Static Population?

What are the Future Directions for Enhanced Sanitation in Epidemiology?

Partnered Content Networks

Relevant Topics